- Home
- CRT vs AIDX Comparison
CRT vs AIDX Comparison
Compare CRT & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRT | AIDX |
|---|---|---|
| Founded | 1991 | N/A |
| Country | United States | United States |
| Employees | 2 | N/A |
| Industry | Oil & Gas Production | Precision Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.3M | 58.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CRT | AIDX |
|---|---|---|
| Price | $9.96 | $1.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 40.8K | ★ 280.5K |
| Earning Date | 03-12-2026 | N/A |
| Dividend Yield | ★ 6.94% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.55 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.07 | $1.87 |
| 52 Week High | $13.31 | $14.09 |
Technical Indicators
Market Signals| Indicator | CRT | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 68.55 | 4.91 |
| Support Level | $9.57 | N/A |
| Resistance Level | $9.99 | $3.08 |
| Average True Range (ATR) | 0.30 | 0.44 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 84.25 | 7.05 |
Price Performance
Historical ComparisonAbout CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.